A decision tool to support appropriate referral for deep brain stimulation in Parkinson’s disease
Elena Moro(Inserm), Niels Allert(Neurologisches Rehabilitationszentrum Leipzig), Tra‐Mi Phan(Medtronic (Ireland)), Roberto Eleopra(Fondazione IRCCS Istituto Neurologico Carlo Besta), Herman Stoevelaar(Barnes-Jewish Hospital), Jean‐Luc Houéto(Inserm)
Cited by 55
Related Papers
Trial of Lixisenatide in Early Parkinson’s Disease
|New England Journal of Medicine|2024|302
Efficacy and Safety of Deep Brain Stimulation in Tourette Syndrome
|JAMA Neurology|2018|241
Effects of <scp>COVID</scp>‐19 on Parkinson's Disease Clinical Features: A <scp>Community‐Based Case‐Control</scp> Study
|Movement Disorders|2020|191